You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology
On demand events

Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

Join Christine Bangert and Perla Lansang for an educational symposium on atopic dermatitis (AD) in children, exploring the diagnosis and pathophysiology of AD in children, the life-long effects of uncontrolled disease beyond the skin, and current and emerging therapies.
Perla Lansang
Christine Bangert
MD
Perla Lansang +1 more

On demand materials

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Epidemiology and Pathophysiology of AD in Children
Dermatology
expert video

Epidemiology and Pathophysiology of AD in Children

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch
Dermatology
expert video

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch

Persistence of AD From Childhood Into Adulthood
Dermatology
expert video

Persistence of AD From Childhood Into Adulthood

Key Treatment Considerations for Management of Atopic Dermatitis in Children
Dermatology
expert video

Key Treatment Considerations for Management of Atopic Dermatitis in Children

Learning objectives

  • Review the diagnosis and pathophysiology of AD in children, with a focus on the role of type 2 inflammation
  • Understand the disease burden and atopic comorbidities of AD, focusing on impacts beyond the skin in children
  • Explore the current and emerging systemic treatment options for children with AD
Tags
symposiumdisease backgroundpediatricmechanism of diseasequality of life
MAT-US-2412448 v1.0 – P Exp. Date: 10/16/2026

About these experts

Dermatology
MD

Perla Lansang

The Hospital for Sick Children Toronto, Canada

Dermatology
MD

Christine Bangert

Medical University of Vienna General Hospital, Vienna, Austria

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region